Obesity resistance and increased energy expenditure by white adipose tissue browning in Oga +/- mice

Diabetologia

Volumn 58, Issue 12, 2015, Pages 2867-2876

  Yang, Yong Ryoul ^a   Jang, Hyun Jun ^a,b   Choi, Sun Sil ^a   Lee, Yong Hwa ^a   Lee, Gyun Hui ^a   Seo, Young Kyo ^a   Choi, Jang Hyun ^a   Park, Dohyun ^b   Koh, Ara ^b   Kim, Il Shin ^a   Lee, Ho ^c   Ryu, Sung Ho ^b   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Adipose tissue browning; Beige adipocyte; O GlcNAcase; O GlcNAcylation; Obesity; Thermogenesis

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; N ACETYLGLUCOSAMINE; O ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG; BETA N ACETYLHEXOSAMINIDASE; GLUCOSE BLOOD LEVEL; HEXOSAMINIDASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOCYTE; CELL DIFFERENTIATION; CLINICAL EVALUATION; CONTROLLED STUDY; EMBRYO; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT MASS; FATTY LIVER; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HAPLOINSUFFICIENCY; HYPER O GLCNACYLATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; METABOLIC RATE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; THERMOGENESIS; WHITE ADIPOSE TISSUE; ANIMAL; BROWN ADIPOSE TISSUE; C57BL MOUSE; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; KNOCKOUT MOUSE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

ACETYLGLUCOSAMINE; ADIPOCYTES, BROWN; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; BLOOD GLUCOSE; BODY WEIGHT; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 84946500719     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3736-z     Document Type: Article

References (39)

1. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825–858
2. Yang X, Ongusaha PP, Miles PD et al (2008) Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451:964–969
3. Whelan SA, Dias WB, Thiruneelakantapillai L, Lane MD, Hart GW (2010) Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem 285:5204–5211
4. Dentin R, Hedrick S, Xie J, Yates J III, Montminy M (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319:1402–1405
5. Housley MP, Rodgers JT, Udeshi ND et al (2008) O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283:16283–16292
6. Guinez C, Filhoulaud G, Rayah-Benhamed F et al (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60:1399–1413
7. Anthonisen EH, Berven L, Holm S, Nygard M, Nebb HI, Gronning-Wang LM (2010) Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem 285:1607–1615
8. Lehman DM, Fu DJ, Freeman AB et al (2005) A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54:1214–1221
9. Farook VS, Bogardus C, Prochazka M (2002) Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 77:189–193
10. Wu J, Bostrom P, Sparks LM et al (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150:366–376
11. Yang YR, Song M, Lee H et al (2012) O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 11:439–448
12. Ji S, Park SY, Roth J, Kim HS, Cho JW (2012) O-GlcNAc modification of PPAR gamma reduces its transcriptional activity. Biochem Biophys Res Commun 417:1158–1163
13. Bullen JW, Balsbaugh JL, Chanda D et al (2014) Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK). J Biol Chem 289:10592–10606
14. Luo B, Parker GJ, Cooksey RC et al (2007) Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J Biol Chem 282:7172–7180
15. Harms M, Seale P (2013) Brown and beige fat: development, function and therapeutic potential. Nat Med 19:1252–1263
16. Yuzwa SA, Macauley MS, Heinonen JE et al (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4:483–490
17. Yang YR, Jang HJ, Yoon S et al (2014) OGA heterozygosity suppresses intestinal tumorigenesis in Apcmin/+ mice. Oncogenesis 3:e109
18. Cao W, Medvedev AV, Daniel KW, Collins S (2001) beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem 276:27077–27082
19. Vosseller K, Wells L, Lane MD, Hart GW (2002) Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 99:5313–5318
20. McClain DA, Lubas WA, Cooksey RC et al (2002) Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A 99:10695–10699
21. Stubbs KA, Macauley MS, Vocadlo DJ (2009) A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells. Angew Chem 48:1300–1303
22. Macauley MS, Vocadlo DJ (2010) Increasing O-GlcNAc levels: an overview of small-molecule inhibitors of O-GlcNAcase. Biochim Biophys Acta 1800:107–121
23. Macauley MS, He YA, Gloster TM, Stubbs KA, Davies GJ, Vocadlo DJ (2010) Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes. Chem Biol 17:937–948
24. Macauley MS, Bubb AK, Martinez-Fleites C, Davies GJ, Vocadlo DJ (2008) Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem 283:34687–34695
25. Macauley MS, Shan X, Yuzwa SA, Gloster TM, Vocadlo DJ (2010) Elevation of global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chem Biol 17:949–958
26. Xing D, Gong K, Feng W et al (2011) O-GlcNAc modification of NFkappaB p65 inhibits TNF-alpha-induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One 6:e24021
27. Yang YR, Kim DH, Seo YK et al (2015) Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-kappaB signaling. Oncotarget 20:12529–12542
28. Olivier-Van Stichelen S, Drougat L, Dehennaut V et al (2012) Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 1:e36
29. Hondares E, Rosell M, Diaz-Delfin J et al (2011) Peroxisome proliferator-activated receptor alpha (PPARalpha) induces PPARgamma coactivator 1alpha (PGC-1alpha) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. J Biol Chem 286:43112–43122
30. Ohno H, Shinoda K, Spiegelman BM, Kajimura S (2012) PPAR gamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15:395–404
31. Kang S, Bajnok L, Longo KA et al (2005) Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol 25:1272–1282
32. Ruan HB, Han X, Li MD et al (2012) O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability. Cell Metab 16:226–237
33. Ha JR, Hao L, Venkateswaran G, Huang YH, Garcia E, Persad S (2014) beta-Catenin is O-GlcNAc glycosylated at serine 23: implications for beta-catenin's subcellular localization and transactivator function. Exp Cell Res 321:153–166
34. Keembiyehetty C, Love DC, Harwood KR, Gavrilova O, Comly ME, Hanover JA (2015) Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis. J Biol Chem 290:7097–7113
35. Zhang Z, Tan EP, VandenHull NJ, Peterson KR, Slawson C (2014) O-GlcNAcase expression is sensitive to changes in O-GlcNAc homeostasis. Front Endocrinol 5:206
36. Ruan HB, Dietrich MO, Liu ZW et al (2014) O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell 159:306–317
37. Khidekel N, Ficarro SB, Peters EC, Hsieh-Wilson LC (2004) Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc Natl Acad Sci U S A 101:13132–13137
38. Taylor EW, Wang K, Nelson AR et al (2014) O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses. J Neurosci 34:10–21
39. Tallent MK, Varghis N, Skorobogatko Y et al (2009) In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. J Biol Chem 284:174–181